Explore Stanford technologies available for licensing:

Low doses of agents that activate BMP signaling (such as FK506) could be used to prevent the progression of bladder cancer and potentially treat breast, colon and other types of epithelial-derived cancer. This technology is based on the discovery by Prof.

Researchers at Stanford have developed a new path planning algorithm that enables autonomous multi-drone aerial surveys over large-scale environments. Their system solves the problem of finding routes over large areas in order to complete aerial survey tasks in reduced time.

Stanford researchers have developed a contrastive learning approach that can significantly reduce the amount of labeled electrocardiogram (ECG) data required for downstream healthcare tasks, such as arrhythmia identification.

Stanford researchers at the Lee Lab have developed a new system and method for measuring pathology then applying a novel algorithm to optimize neurostimulation therapy for altering pathology for treatment of neurodegenerative diseases.

Stanford researchers in the Onori Lab have developed a method for accurately estimating battery state-of-charge (SOC) using the inverse derivative of galvanostatic voltage response (dQ/dV) curve.

Researchers at Stanford and their colleagues have developed cell culture media, known as LPM-3D, to grow a pure population of multipotent lung stem cells in culture.

Mechanical engineers at Stanford have patented a soft robot with a vine-like structure capable of growing over 100 times in length.

Stanford researchers have synthesized a highly effective molecule to transport drug conjugates across cell membranes.

Exhausted T cells are T cells that become dysfunctional after a period of time and play a role in reduced efficacy of T cell targeted immunotherapies.

Background

Different drug delivery agents, including synthetic polymers, virus-based vectors, lipid-based vectors, and extracellular vesicles (EVs), have been explored previously.

This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.

Researchers at Stanford have identified amino acid modifications in the IgG Fc region which extend its therapeutic half-life and improve its in vivo receptor binding.

Researchers in Dr. Karl Deisseroth's lab have developed a selective approach to treat anxiety. Anxiety is characterized by several features that are coordinately regulated by diverse neuronal system outputs.

Stanford researchers in the McNab lab have developed a marker-less neuro-navigation device that only needs to be setup once during the first transcranial magnetic stimulation (TMS) session and by tracking the subjects head, automatically achieves the same accurate coil locatio